TET‐catalyzed oxidation of intragenic 5‐methylcytosine regulates CTCF‐dependent alternative splicing

• DOI: 10.15252/embj.201593235
• Publication Date: 2015-12-29T03:14:07Z
• Authors: Ryan J Marina; David Sturgill; Marc A Bailly; Morgan Thenoz; Garima Varma; Maria F Prigge; Kyster K Nanan; Sanjeev Shukla; Nazmul Haque; Shalini Oberdoerffer
• Keywords: 0301 basic medicine; CCCTC-Binding Factor; Cell Line; Dioxygenases; Mixed Function Oxygenases; DNA-Binding Proteins; Repressor Proteins; Alternative Splicing; 03 medical and health sciences; Proto-Oncogene Proteins; 5-Methylcytosine; Humans; Oxidation-Reduction

AbstractIntragenic 5‐methylcytosine and CTCF mediate opposing effects on pre‐mRNA splicing: CTCF promotes inclusion of weak upstream exons through RNA polymerase II pausing, whereas 5‐methylcytosine evicts CTCF, leading to exon exclusion. However, the mechanisms governing dynamic DNA methylation at CTCF‐binding sites were unclear. Here, we reveal the methylcytosine dioxygenases TET1 and TET2 as active regulators of CTCF‐mediated alternative splicing through conversion of 5‐methylcytosine to its oxidation derivatives. 5‐hydroxymethylcytosine and 5‐carboxylcytosine are enriched at an intragenic CTCF‐binding sites in the CD45 model gene and are associated with alternative exon inclusion. Reduced TET levels culminate in increased 5‐methylcytosine, resulting in CTCF eviction and exon exclusion. In vitro analyses establish the oxidation derivatives are not sufficient to stimulate splicing, but efficiently promote CTCF association. We further show genomewide that reciprocal exchange of 5‐hydroxymethylcytosine and 5‐methylcytosine at downstream CTCF‐binding sites is a general feature of alternative splicing in naïve and activated CD4+ T cells. These findings significantly expand our current concept of the pre‐mRNA “splicing code” to include dynamic intragenic DNA methylation catalyzed by the TET proteins.